China Emerges as a Global Powerhouse in Drug Innovation

China's pharmaceutical industry has rapidly transformed from the world's low-cost manufacturer into a leading center for drug discovery. It is now the second-largest developer of new medicines globally, trailing only the United States. The country's growth in this field has been remarkable. Its share of the global drug development pipeline jumped from just 3% in 2013 to a significantly larger portion today. This shift results from a focused national strategy. China moved beyond producing basic pharmaceutical ingredients to engineering a full innovation ecosystem. The government prioritized major funding, streamlined regulations, and encouraged overseas-trained scientists to return. These actions created a powerful engine for developing new and more effective treatments.